We previously reported that selective ablation of the nuclear receptors retinoid X receptor (RXR)-α and RXR-β in mouse epidermal keratinocytes (RXR-αβ ep−/− ) or a topical application of active vitamin D3 (VD3) and/or all-trans retinoic acid (RA) on wild-type mouse skin induces a human atopic dermatitis-like phenotype that is triggered by an increased expression of the thymic stromal lymphopoietin (TSLP) proinflammatory cytokine. We demonstrate here that in epidermal keratinocytes, unliganded heterodimers of vitamin D receptor (VDR)/RXR-α and retinoic acid receptor-γ (RAR-γ)/RXR-β are bound as repressing complexes to their cognate DNA-binding sequence(s) (DBS) in the TSLP promoter regulatory region. Treatments with either an agonistic VD3 analog or RA dissociate the repressing complexes and recruit coactivator complexes and RNA polymerase II, thereby inducing transcription. Furthermore, we identified several functional NF-κB, activator protein 1 (AP1), STAT, and Smad DBS in the TSLP promoter region. Interestingly, many of these transcription factors and DBS present in the TSLP promoter region are differentially used in intestinal epithelial cell(s) (IEC). Collectively, our study reveals that, in vivo within their heterodimers, the RXR and RAR isotypes are not functionally redundant, and it also unveils the combinatorial mechanisms involved in the tissue-selective regulation of TSLP transcription in epidermal keratinocytes and IEC.TSLP transcription | nuclear receptors | skin | intestine | NF-κB W e reported that keratinocyte-selective ablation of retinoid X receptor (RXR)-α and RXR-β in epidermal keratinocytes of the mouse (RXR-αβ ep−/− mutants) results in a skin and systemic syndrome that mimics human atopic dermatitis (AD) and is preceded, in epidermal keratinocytes, by enhanced expression of the thymic stromal lymphopoietin (TSLP) cytokine (1). Moreover, several lines of evidence have revealed that TSLP expression is both necessary and sufficient to induce an atopic inflammation in the mouse (1-4). TSLP, which is also expressed in human AD skin lesions (5, 6), has been considered to be the master regulator of allergic inflammation (7).Interestingly, the TSLP promoter region was found to contain several putative nuclear receptor (NR) DNA-binding sequence(s) (DBS) (2). Topical treatment with active vitamin D3 [1α, 25(OH)2 (VD3)] or its low-calcemic analog calcipotriol (also named MC903; hereafter, MC), all-trans retinoic acid (RA), and the retinoic acid receptor-γ (RAR-γ)-selective retinoid BMS961, which are agonistic ligands for vitamin D receptor (VDR), all three RARs, and RAR-γ, respectively, could induce TSLP expression in mouse keratinocytes on their own or synergistically (2). However, MC was more efficient than BMS961 at inducing TSLP expression in these cells, and longterm treatment with MC resulted in an AD-like syndrome similar to the syndrome observed in RXR-αβ ep−/− mice. To reveal how both the keratinocyte-selective ablation of RXR-α and RXR-β (RXR-γ is not expressed in keratinocytes) or MC and/or ...